Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12241
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpong, Jen
dc.contributor.authorKennedy, G Aen
dc.contributor.authorTseng, Jen
dc.contributor.authorBrown, Douglas Jen
dc.contributor.authorArmstrong, S Men
dc.contributor.authorBerlowitz, David Jen
dc.date.accessioned2015-05-16T01:53:59Z
dc.date.available2015-05-16T01:53:59Z
dc.date.issued2014-06-03en
dc.identifier.citationSpinal Cord 2014; 52(8): 629-34en
dc.identifier.govdoc24891007en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12241en
dc.description.abstractRandomised, double-blind, placebo-controlled crossover trial of melatonin supplementation to people with complete tetraplegia.To investigate the effect that 3 mg melatonin supplementation has on objective and subjective sleep, quality of life and mood of people living with complete tetraplegia.Austin Hospital Sleep Laboratory and participants' homes, Melbourne, Victoria, Australia.Two week run-in followed by 3 week nightly administration of 3 mg melatonin or placebo, 2-week washout and further 3 week administration of the opposite treatment. Four testing sessions were conducted; the last nights of the run-in, treatment and washout periods. Testing sessions involved recording full polysomnography, completing a questionnaire battery and collecting urine and blood samples. The questionnaires assessed mood, sleep symptoms and health-related quality of life, and the urine and plasma samples assayed 6-sulphatoxymelatonin (aMT6s) and melatonin levels, respectively. A sleep diary was completed throughout the study.Eight participants (mean (s.d.): age 49.5 years (16), postinjury 16.9 years (7.1)) were recruited in which seven concluded the protocol. Endogenous-circulating melatonin was significantly higher (P < or = 0.01) following melatonin (urine: 152.94 μg h(-1) (74.51), plasma: 43,554.57 pM (33,527.11)) than placebo (urine: 0.86 μg h(-1) (0.40), plasma: 152.06 pM (190.55)). Subjective sleep improved significantly following melatonin specifically for duration of sleep per night and psychological wellbeing. Objective sleep showed a significant increase in light sleep with melatonin, with all other sleep parameters being unchanged.These results suggest that increasing melatonin in people with complete tetraplegia is beneficial, especially for subjective sleep. Investigation of the pharmacokinetics of melatonin metabolism in this population is warranted.This project is proudly supported by the Transport Accident Commission.en
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherAffect.drug effectsen
dc.subject.otherAgeden
dc.subject.otherAntioxidants.metabolism.therapeutic useen
dc.subject.otherCross-Over Studiesen
dc.subject.otherDouble-Blind Methoden
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMelatonin.analogs & derivatives.blood.therapeutic use.urineen
dc.subject.otherMiddle Ageden
dc.subject.otherPolysomnographyen
dc.subject.otherQuadriplegia.complications.drug therapy.psychologyen
dc.subject.otherQuality of Lifeen
dc.subject.otherQuestionnairesen
dc.subject.otherSleep Disorders.blood.drug therapy.etiology.urineen
dc.titleSleep disruption in tetraplegia: a randomised, double-blind, placebo-controlled crossover trial of 3 mg melatonin.en
dc.typeJournal Articleen
dc.identifier.journaltitleSpinal corden
dc.identifier.affiliationInstitute for Breathing and Sleep, Austin Hospital, Melbourne, Victoria, Australia.en
dc.identifier.affiliation1] Institute for Breathing and Sleep, Austin Hospital, Melbourne, Victoria, Australia [2] Psychology Department, College of Arts, Victoria University, Melbourne, Victoria, Australia [3] The Bronowski Institute of Behavioural Neuroscience, Kyneton, Victoria, Australia.en
dc.identifier.affiliationDepartment of Emergency Medicine, The Northern Hospital, Melbourne, Victoria, Australia.en
dc.identifier.affiliationSpinal Research Institute, Austin Health, Melbourne, Victoria, Australia.en
dc.identifier.affiliation1] The Bronowski Institute of Behavioural Neuroscience, Kyneton, Victoria, Australia [2] Epworth Sleep Centre, Melbourne, Victoria, Australia.en
dc.identifier.affiliation1] Institute for Breathing and Sleep, Austin Hospital, Melbourne, Victoria, Australia [2] Spinal Research Institute, Austin Health, Melbourne, Victoria, Australia [3] Department of Medicine, Austin Health and Northern Health, University of Melbourne, Melbourne, Victoria, Australia.en
dc.identifier.doi10.1038/sc.2014.84en
dc.description.pages629-34en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/24891007en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.